Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports
doi 10.33140/jcrc/04/01/00008
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Opast Group LLC

Related search

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine
Medicine
2006English

Role of Interleukin 33 in Neovascular Age-Related Macular Degeneration

The Lancet
Medicine
2016English

Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2017English

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Ophthalmology and Therapy
Ophthalmology
2016English

Treatment of Age-Related Neovascular Macular Degeneration: The Patient’s Perspective

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2016English

Reproducibility of Macular Thickness Measurements Using Cirrus SD-OCT in Neovascular Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Neovascular Age-Related Macular Degeneration Is Associated With Cataract Surgery

Acta Ophthalmologica
MedicineOphthalmology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy